| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 5.832 | 9.120 | 8.141 | 7.765 | 7.939 | 9.943 | 9.016 | 10.617 | 32.800 |
| Total Income - EUR | 0 | 5.832 | 9.120 | 8.141 | 7.765 | 8.644 | 9.943 | 9.016 | 10.617 | 32.800 |
| Total Expenses - EUR | 0 | 6.487 | 11.245 | 11.621 | 12.183 | 10.780 | 5.022 | 5.954 | 11.355 | 10.933 |
| Gross Profit/Loss - EUR | 0 | -655 | -2.125 | -3.481 | -4.418 | -2.136 | 4.920 | 3.061 | -738 | 21.867 |
| Net Profit/Loss - EUR | 0 | -795 | -2.216 | -3.562 | -4.496 | -2.306 | 4.622 | 2.837 | -844 | 20.932 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Magraldi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 115 | 863 | 475 | 16 | 0 | 14 | 32 | 1 | 0 | 0 |
| Current Assets | 155 | 1.810 | 1.639 | 1.858 | 1.280 | 1.016 | 730 | 1.151 | 742 | 17.355 |
| Inventories | 0 | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 852 | 0 | 0 | 3 | 1 | 1 | 8.060 |
| Cash | 155 | 1.768 | 1.639 | 1.007 | 1.280 | 1.016 | 727 | 1.150 | 741 | 9.295 |
| Shareholders Funds | 45 | -751 | -2.954 | -6.462 | -10.833 | -12.934 | -8.025 | -5.212 | -6.041 | 14.926 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 225 | 3.445 | 5.099 | 8.337 | 12.125 | 13.964 | 8.786 | 6.383 | 6.822 | 2.481 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Magraldi Srl